Spectrum Menu Beta V2.0.1 Free
The application below lets you use SDSS's templates to find the redshifts of ten galaxies. Select the spectrum you wish to look at with the drop-down menu labeled "spectrum." Select the template you wish to compare it to with the drop-down menu labeled "template." Compare each spectrum to the nine templates to find the one it most resembles (the spectrum is blue and the template is yellow). Then, use the left, right, step left () buttons at the bottom of the page to move the unknown spectrum left and right. Above the spectrum, the application shows the redshift you are testing.
Spectrum Menu Beta v2.0.1
When the peaks and valleys of the unknown spectrum match with the peaks and valleys of one of the templates, you have found the redshift of the unknown spectrum. Don't try to match the entire spectrum perfectly; just get the major peaks and valleys to match. When you find the redshift that matches the spectrum most closely, write the spectrum number from the drop-down menu, then write the redshift you found.
Select any plate from the dropdown menu. Below the menu, you will see 640 links, labeled with object type (star, galaxy, or quasar) and redshift. When you click a link, you will see the spectrum of that object.
The application below lets you use SDSS's templates to find the redshifts of ten galaxies. Select the spectrum you wish to look at with the drop-down menu labeled "spectrum." Select the template you wish to compare it to with the drop-down menu labeled "template." Compare each spectrum to the nine templates to find the one it most resembles. Then, use the left, right, step forward (>>) and step backward (
The easiest way to examine several spectra at once is to use the Plate Browser tool. Choose any plate from the dropdown menu, then click on any of the "galaxy" links to see a spectrum. The redshift is the "z" value written at the bottom of each spectrum.
A WinAmp spectrum analyzer plugin is now available for download.The bignum, perf and menu plugins have been re-released as betas; thiswas due to the low (or zero) bug counts. An iTunes plugin has beenwritten by Gareth Price. A Sage TV plugin has been written by AndersNolberger. A Meedio Plugin by Harald Wagner. A WinAmp title splittingplugin by Limbo. And there are many more plugins currently in progress!
A central focus will be the evaluation of the beta energy dependence of decay observables, including the total decay spectrum (with the goal of understanding the spectrum to better than 10-4 for 6He, the A=8 system, 14O, 19Ne), and and angular correlations, where new techniques promise, in principle, sensitivity below the 0.1% level, but will also assess the role of ongoing integral angular correlation work in neutrons and nuclei. The evaluation will involve an assessment of the most promising experimental approaches and the theoretical input required to achieve the highest sensitivity to new physics for these measurements. Through dialog involving theorists and experimentalists, we expect to identify critical theory needs and the resources to address the identified problems. Some attention to important BSM scenarios and how to develop these in light of the results from the LHC will also be addressed. We plan to produce a white paper describing the most promising experiments, the theoretical issues which must be addressed, and the resources required to address them.
Resistance to antibacterial drugs is a global problem that poses a great threat to patient health.1 In addition to antimicrobial stewardship efforts, the development of novel antibacterial drugs is necessary to address this problem and preserve the efficacy of currently available antibiotics. Several common pathogens, such as Staphylococcus aureus, Enterococcus faecium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, andEnterobacter species, have developed resistance mechanisms that are particularly difficult to treat. Escherichia coli, K pneumoniae, P aeruginosa, A baumannii, and Enterobacter species are capable of expressing extended spectrum beta-lactamases (ESBLs), a resistance mechanism that can inactivate third- and fourth-generation cephalosporins.2 Recently, the development of avibactam, a novel beta-lactamase inhibitor, has introduced a new way to combat ESBL inactivation of ceftazidime in the form of a ceftazidime/avibactam (CAZ-AVI) combination product.
Ceftazidime is a third-generation cephalosporin.2 Avibactam is a non-β-lactam beta-lactamase inhibitor with no direct antibacterial activity.3,6 The combination product is designed to expand the activity of ceftazidime in the presence of ESBL-producing gram-negative bacilli.2,6 Table 1 provides a summary of the spectrum of activity of CAZ-AVI.6 041b061a72